PR Newswire D3 Bio Receives U.S. FDA Clearance for Two IND Applications, Enabling Phase 1 Trial of D3S‑003 and Phase 2 Combination Study of Elisrasib (D3S‑001) with D3S‑002 by Money Compass January 19, 2026
PR Newswire A Smarter New Year’s Resolution: Investing in Eye Comfort for Screen Heavy Workdays by Money Compass January 19, 2026
PR Newswire A Smarter New Year’s Resolution: Investing in Eye Comfort for Screen Heavy Workdays by Money Compass January 19, 2026
PR Newswire Elliott Opposes Toyota Fudosan’s Revised Tender Offer for Toyota Industries Corporation by Money Compass January 18, 2026
PR Newswire Elliott Opposes Toyota Fudosan’s Revised Tender Offer for Toyota Industries Corporation by Money Compass January 18, 2026
PR Newswire Taptouch Introduces Australia’s First Locally Built Embedded Payments POS by Money Compass January 18, 2026
PR Newswire Taptouch Introduces Australia’s First Locally Built Embedded Payments POS by Money Compass January 18, 2026
PR Newswire New Year’s Resolution for Families: Supporting Children’s Eye Health at Home by Money Compass January 18, 2026
PR Newswire AiMOGA Robot Family Debuts at the 2026 Chery AI Night, Showcasing Diverse Real-World Applications by Money Compass January 18, 2026
PR Newswire World’s First Cylindrical Battery Lighthouse Factory: EVE Energy Sets a New Benchmark in Smart Manufacturing by Money Compass January 18, 2026
